002219: New Journey Health Technology Group Co.,LTD - Summary | Jitta

New Journey Health Technology Group Co.,LTD

CHN:002219

Price
CN¥2.17
Loss Chance
54.1%
2.34JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
298 / 486
2,990 / 5,265
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (19)
Recent Business Performance (20)
Financial Strength (62)
Return to Shareholders (4)
Competitive Advantage (27)
Jitta Signs
SG&A to SalesDecreasing
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2021
Operating MarginDeclined
Recent Business PerformanceEarning decline 29.53% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.34
> 1,000%
4.23
> 1,000%
Health Care Facilities
3.02
> 1,000%
1.28
> 1,000%
3.17
> 1,000%
COMPANY DESCRIPTION
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Schisandra tablets, Maiping tablets, Prosta Antong tablets, Gongzhongning capsules, Wuhu San, Wei Funing capsules, and other proprietary Chinese medicine products. In addition, it engages in Chinese herbal medicine planting; investment management; retail business; wholesale trading activities; and provision of resident services. The company was formerly known as Hengkang Medical Group Co.,Ltd. New Journey Health Technology Group Co.,LTD was founded in 2001 and is headquartered in Beijing, China.